Department of Statistics, Debre Markos University, Debre Markos, Ethiopia.
BMC Endocr Disord. 2022 May 23;22(1):136. doi: 10.1186/s12902-022-01047-x.
Microvascular complications lead to disability, dependency, and accelerated morbidity and mortality. This study aimed to identify predictors of blood glucose change and time to microvascular complications among patients with type 2 diabetes.
A retrospective cohort study was conducted among type 2 diabetes mellitus patients enrolled between December 2014 and December 2015 at Felege Hiwot and Debre Markos Referral Hospital. A total of 318 T2DM patients were included in the study. Joint modelling of longitudinal and survival analysis was employed to identify predictors of Blood Glucose Change and Microvascular Complications in Type 2 Diabetes Mellitus Patients.
The prevalence of microvascular complications in Type 2 diabetes patients was 26.3%, 95%confidence interval(CI):(21.5, 31.1). Of which, half of the patients developed a microvascular complication after 30 months from the onset of the follow-up. The significant predictors of developing microvascular complication were positive proteinurea (adjusted hazard ratio (AHR) = 1.418, 95%CI: 1.080, 1.861), Serum creatinine (AHR = 3.704, 95%CI: 1.992, 6.887), Weight (AHR = 1.058, 95%CI: 1.023, 1.094), and log fasting blood glucose(log(FBS))(AHR = 1.013, 95%CI: 1.010, 1.015). The predictors of fasting blood glucose progression were higher baseline FBS(est(estimate) = 0.002,95%CI:0.0018, 0.0022), Systolic blood pressure (SBP) (est = 0.003, 95%CI: 0.002, 0.004), diastolic blood pressure (DBP) (est = 0.002, 95%CI: 0.0002, 0.004), and age (est = 0.003, 95%CI: 0.001, 0.004).
The progression of the fasting blood glucose level for rural patients was faster than for urban patients. Patients having higher baseline FBS, previous hypertension history, higher SBP, higher DBP, older age, and fewer visits to the hospital have a relatively more progressive change in blood sugar levels. Patients having higher triglyceride levels, positive proteinuria, higher fasting blood sugar, higher weight, and a lesser number of hospital visits have a higher risk of developing a complication. In response to this finding, an aggressive intervention that targets to prevent microvascular complications is required.
微血管并发症导致残疾、依赖和加速发病和死亡。本研究旨在确定 2 型糖尿病患者血糖变化和微血管并发症发生时间的预测因素。
这是一项回顾性队列研究,纳入了 2014 年 12 月至 2015 年 12 月在 Felege Hiwot 和 Debre Markos 转诊医院登记的 2 型糖尿病患者。共有 318 名 T2DM 患者纳入本研究。采用纵向和生存联合模型分析来确定 2 型糖尿病患者血糖变化和微血管并发症的预测因素。
2 型糖尿病患者微血管并发症的患病率为 26.3%,95%置信区间(CI)为(21.5,31.1)。其中,一半的患者在随访开始后 30 个月出现微血管并发症。发生微血管并发症的显著预测因素是蛋白尿阳性(校正风险比(AHR)= 1.418,95%CI:1.080,1.861)、血清肌酐(AHR= 3.704,95%CI:1.992,6.887)、体重(AHR= 1.058,95%CI:1.023,1.094)和空腹血糖(log(FBS))(AHR= 1.013,95%CI:1.010,1.015)。空腹血糖进展的预测因素是较高的基线 FBS(估计值= 0.002,95%CI:0.0018,0.0022)、收缩压(SBP)(估计值= 0.003,95%CI:0.002,0.004)、舒张压(DBP)(估计值= 0.002,95%CI:0.0002,0.004)和年龄(估计值= 0.003,95%CI:0.001,0.004)。
农村患者的空腹血糖水平进展速度快于城市患者。基线 FBS 较高、既往有高血压病史、SBP 较高、DBP 较高、年龄较大、就诊次数较少的患者血糖水平变化相对较快。甘油三酯水平较高、蛋白尿阳性、空腹血糖较高、体重较高、就诊次数较少的患者发生并发症的风险较高。针对这一发现,需要采取积极的干预措施来预防微血管并发症。